Related Experiment Video
Updated: Dec 5, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders
1Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Marine omega-3 polyunsaturated fatty acids (n-3 PUFAs), including eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), can combat chronic inflammation. These fatty acids show promise in modulating disease progression in various animal models.
Area of Science:
- Biomedical Science
- Molecular Biology
- Nutrition Science
Background:
- Inflammation is a natural healing response but can become chronic, leading to disease.
- Chronic inflammation is linked to tissue damage and non-communicable diseases.
- Marine n-3 polyunsaturated fatty acids (n-3 PUFAs) influence inflammatory processes.
Purpose of the Study:
- To review the role of n-3 PUFAs in modulating inflammation.
- To explore the therapeutic potential of n-3 PUFAs in disease models.
- To summarize experimental and clinical data on n-3 PUFAs and inflammation.
Main Methods:
- Literature review of experimental studies in animal models.
- Analysis of data from clinical trials.
- Focus on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Main Results:
- n-3 PUFAs demonstrate the ability to modulate inflammatory mechanisms.
- Studies in obesity, Alzheimer's, and multiple sclerosis models show n-3 PUFA effects.
- Evidence suggests n-3 PUFAs can impact disease progression.
Conclusions:
- Marine n-3 PUFAs, particularly EPA and DHA, show significant potential in managing chronic inflammation.
- Further research from experimental to clinical levels supports their therapeutic value.
- n-3 PUFAs represent a promising nutritional strategy against inflammation-related diseases.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Atherosclerosis III: Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Ulcerative Colitis in IBD